Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 15, 2008 - Issue 1
347
Views
76
CrossRef citations to date
0
Altmetric
Original Article

Gender-related risk of myocardial involvement in systemic amyloidosis

, , , , , , , , , , , , , , , , & show all
Pages 40-48 | Published online: 06 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Grégoire Albenque, Mélanie Bézard, Mounira Kharoubi, Shirley Odouard, Ariane Lunati, Elsa Poullot, Amira Zaroui, Emmanuel Teiger, Luc Hittinger, Vincent Audard, Khalil El Karoui, Benoît Funalot, Pascale Fanen, Thibaud Damy & Silvia Oghina. (2023) Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study. Amyloid 30:4, pages 407-415.
Read now
Jonah Rubin, Julissa Alvarez, Sergio Teruya, Adam Castano, Ronald A. Lehman, Mark Weidenbaum, Jeffrey A. Geller, Stephen Helmke & Mathew S. Maurer. (2017) Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?. Amyloid 24:4, pages 224-228.
Read now
Taxiarchis V Kourelis & Morie A Gertz. (2015) Improving strategies for the diagnosis of cardiac amyloidosis. Expert Review of Cardiovascular Therapy 13:8, pages 945-961.
Read now
Amanda Tendler, Stephen Helmke, Sergio Teruya, Julissa Alvarez & Mathew S. Maurer. (2015) The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid 22:1, pages 61-66.
Read now
Alejandra González-Duarte, Mónica Lem-Carrillo & Karla Cárdenas-Soto. (2013) Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy. Amyloid 20:4, pages 221-225.
Read now
Ole B Suhr, Sandra Gustavsson, Victoria Heldestad, Rolf Hörnsten, Per Lindqvist, Erik Nordh & Urban Wiklund. (2012) New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center’s experience. Degenerative Neurological and Neuromuscular Disease 2, pages 93-106.
Read now
Alejandra González-Duarte, Karla Cárdenas Soto, Deborah Martínez-Baños, Jazmin Arteaga-Vazquez, Fausto Barrera, Mauricio Berenguer-Sanchez, Carlos Cantu-Brito, Guillermo García-Ramos & Bruno Estañol Vidal. (2012) Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid 19:4, pages 171-176.
Read now
Claudio Rapezzi, Simone Longhi, Agnese Milandri, Massimiliano Lorenzini, Christian Gagliardi, Ilaria Gallelli, Ornella Leone & Candida Cristina Quarta. (2012) Cardiac involvement in hereditary-transthyretin related amyloidosis. Amyloid 19:sup1, pages 16-21.
Read now
Sadahisa Okamoto, Ying Zhao, Per Lindqvist, Christer Backman, Bo-Göran Ericzon, Priyantha Wijayatunga, Michael Y. Henein & Ole B. Suhr. (2011) Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients. Amyloid 18:4, pages 200-205.
Read now
S. Okamoto, J. Wixner, B.-G. Ericzon, S. Friman, P. Lindqvist, M. Henein & O. B. Suhr. (2011) Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy. Amyloid 18:sup1, pages 171-173.
Read now
Minori Kodaira, Hiroshi Morita, Yoshio Shimojima & Shu-ichi Ikeda. (2011) Electrophysiological features of familial amyloid polyneuropathy in endemic area. Amyloid 18:1, pages 10-18.
Read now
Rolf Hörnsten, Johanna Pennlert, Urban Wiklund, Per Lindqvist, Steen M. Jensen & Ole B. Suhr. (2010) Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 17:2, pages 63-68.
Read now

Articles from other publishers (64)

Sandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Mayur Doke, Mukesh Roy, Juan Gabriel Ruiz-Pelaez, Yanjia Zhang, Ashfaq Ahmed, Zhenwei Zhang, Peter McGranaghan, Sandra Chaparro & Javier Jimenez. (2023) Adverse Outcomes in Hospitalizations for Amyloid-Related Heart Failure. The American Journal of Cardiology 203, pages 169-174.
Crossref
Alberto Aimo, Giorgia Panichella, Manuel Garofalo, Simone Gasparini, Chiara Arzilli, Vincenzo Castiglione, Giuseppe Vergaro, Michele Emdin & Silvia Maffei. (2023) Sex differences in transthyretin cardiac amyloidosis. Heart Failure Reviews.
Crossref
Monica Embry-Dierson, Mary Beth Farrell, Eric Schockling, Jaime Warren & Scott Jerome. (2023) Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition. Journal of Nuclear Medicine Technology 51:2, pages 83-89.
Crossref
Aldostefano Porcari, Yousuf Razvi, Ambra Masi, Rishi Patel, Adam Ioannou, Muhammad U. Rauf, David F. Hutt, Dorota Rowczenio, Janet Gilbertson, Ana Martinez‐Naharro, Lucia Venneri, Carol Whelan, Helen Lachmann, Ashutosh Wechalekar, Candida Cristina Quarta, Marco MerloGianfranco Sinagra, Philip N. Hawkins, Marianna Fontana & Julian D. Gillmore. (2023) Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy . European Journal of Heart Failure 25:4, pages 515-524.
Crossref
Thomas Zegkos, Thomas Gossios, Dimitris Ntelios, Despoina Parcharidou, Haralampos Karvounis & Georgios Efthimiadis. (2021) Wild-Type Transthyretin Amyloid Cardiomyopathy: The Gordian-Knot of Novel Therapeutic Regimens. Cardiology in Review 31:1, pages 36-41.
Crossref
Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt V. Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman, Leslie Amass, Pablo Garcia Pavia, Ivaylo Tarnev, Jose Gonzalez Costello, Maria Alejandra Gonzalez Duarte Briseno, Hartmut Schmidt, Brian Drachman, Fabio Adrian Barroso, Taro Yamashita, Olivier Lairez, Yoshiki Sekijima, Giuseppe Vita, Eun-Seok Jeon, Mazen Hanna, David Slosky, Marco Luigetti, Samantha LoRusso, Francisco Munoz Beamud, David Adams, Henning Moelgaard, Rayomand Press, Calogero Lino Cirami, Hans Nienhuis, Josep Maria Campistol Plana, Jocelyn Inamo, Daniel Jacoby, Michele Emdin, Dianna Quan, Scott Hummel, Ronald Witteles, Amir Dori, Sanjiv Shah, Daniel Lenihan, Olga Azevedo, Srinivas Murali, Sasa Zivkovic, Soon Chai Low, Jose Nativi-Nicolau, Nowell Fine, Jose Tallaj, Carsten Tschoepe, Roberto Fernandéz Torrón, Michael Polydefkis, Giampaolo Merlini, Sorina Badelita, Stephen Gottlieb, James Tauras, Edileide Barros Correia, Hector Ventura, Burkhard Gess, Felix Darstein, Jeeyoung Oh, Tessa Marburger, Johan Van Cleemput, Valeria Lujan Salutto, Yesim Parman, Chi-Chao Chao, Nitasha Sarswat, Christopher Mueller, David Steidley, Jeffrey Ralph, Alberta Warner, William Cotts, James Hoffman, Marcelo Rugiero, Sonoko Misawa, Jose Luis Munoz Blanco, Lucia Galan Davila, Menachem Sadeh, Jin Luo, Theodoros Kyriakides, Annabel Wang, Horacio Kaufmann & Sasa Zivkovic. (2022) Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update. Orphanet Journal of Rare Diseases 17:1.
Crossref
Claudio Rapezzi, Michele Emdin & Alberto Aimo. (2022) Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis. European Journal of Heart Failure 24:12, pages 2364-2366.
Crossref
Rishi K. Patel, Adam Ioannou, Yousuf Razvi, Liza Chacko, Lucia Venneri, Francesco Bandera, Daniel Knight, Tushar Kotecha, Ana Martinez‐Naharro, Ambra Masi, Aldostefano Porcari, James Brown, Kiara Patel, Charlotte Manisty, James Moon, Dorota Rowczenio, Janet A. Gilbertson, Gianfranco Sinagra, Helen Lachmann, Ashutosh Wechalekar, Aviva Petrie, Carol Whelan, Philip N. Hawkins, Julian D. Gillmore & Marianna Fontana. (2022) Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis. European Journal of Heart Failure 24:12, pages 2355-2363.
Crossref
Christy N. Taylor & Emily S. Lau. (2022) Sex Differences in Cardiomyopathy. Current Cardiovascular Risk Reports 16:11, pages 159-170.
Crossref
Courtney M. Campbell, Samantha LoRusso, Angela Dispenzieri, Arnt V. Kristen, Mathew S. Maurer, Claudio Rapezzi, Olivier Lairez, Brian Drachman, Pablo Garcia-Pavia, Martha Grogan, Doug Chapman, Leslie Amass, Michele Emdin, Mazen Hanna, Olga Azevedo, Calogero Lino Cirami, Daniel Jacoby, Jose Gonzalez Costello, David Slosky, Henning Moelgaard, Scott Hummel, Jose Nativi-Nicolau, Srinivas Murali, Nowell Fine, Eun-Seok Jeon, Sanjiv Shah, Ronald Witteles, Daniel Lenihan, Marcia Waddington-Cruz, Yoshiki Sekijima, Jose Tallaj, Christopher Mueller, Johan Van Cleemput, Violaine Planté-Bordeneuve, Hans Nienhuis, Dianna Quan, David Steidley, Hartmut Schmidt, Jonas Wixner, Michael Polydefkis, Jeffrey Ralph, Hector Ventura, Sasa Zivkovic, Burkhard Gess, Roberto Fernandéz Torrón, Stephen Gottlieb, William Cotts, James Tauras, Nitasha Sarswat, Juan González Moreno, Yesim Parman & Jin Luo. (2022) Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Cardiology and Therapy 11:3, pages 393-405.
Crossref
Farhan Bajwa, Ryan O’Connor & Karthikeyan Ananthasubramaniam. (2021) Epidemiology and clinical manifestations of cardiac amyloidosis. Heart Failure Reviews 27:5, pages 1471-1484.
Crossref
Hiroki Kitakata, Hidenori Moriyama, Jin Endo, Hidehiko Ikura, Keiichi Fukuda & Motoaki Sano. (2022) Treatment of transthyretin His88Arg amyloidosis with RNA interference therapy: A case report. Journal of Cardiology Cases 25:6, pages 363-366.
Crossref
Chukwuemeka A. Obi, William C. Mostertz, Jan M. Griffin & Daniel P. Judge. (2022) ATTR Epidemiology, Genetics, and Prognostic Factors. Methodist DeBakey Cardiovascular Journal 18:2, pages 17-26.
Crossref
Ko Harada, Hideharu Hagiya, Toshihiro Koyama & Fumio Otsuka. (2022) Trends in the amyloidosis mortality rate in J apan: A nationwide observational study from 1998 to 2019 . Geriatrics & Gerontology International 22:3, pages 246-250.
Crossref
Mattia Zampieri, Alessia Argirò, Marco Allinovi, Luigi Tassetti, Chiara Zocchi, Martina Gabriele, Valentina Andrei, Carlo Fumagalli, Carlo Di Mario, Alessia Tomberli, Iacopo Olivotto, Federico Perfetto & Francesco Cappelli. (2022) Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. International Journal of Cardiology 351, pages 71-77.
Crossref
Hidehiko Ikura, Hiroki Kitakata, Jin Endo, Hidenori Moriyama, Motoaki Sano, Hanako Tsujikawa, Mitsuaki Sawano, Teruaki Masuda, Takahiro Ohki, Mitsuharu Ueda, Kenjiro Kosaki & Keiichi Fukuda. (2022) Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant. European Journal of Medical Genetics 65:3, pages 104451.
Crossref
Enrico Ammirati & Omar F AbouEzzeddine. (2022) Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives. European Heart Journal 43:5, pages 401-404.
Crossref
Thibaud Damy, Arnt V Kristen, Ole B Suhr, Mathew S Maurer, Violaine Planté-Bordeneuve, Ching-Ray Yu, Moh-Lim Ong, Teresa Coelho & Claudio Rapezzi. (2022) Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). European Heart Journal 43:5, pages 391-400.
Crossref
J.-B. Davion, P. Bocquillon, F. Cassim, N. Frezel, A. Lacour, C.-M. Dhaenens, C.-A. Maurage, J.-B. Gibier, E. Hachulla, S. Nguyen The Tich, L. Defebvre, P.-E. Merle & C. Tard. (2021) Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France. Revue Neurologique 177:9, pages 1160-1167.
Crossref
Pranav Chandrashekar, Laith Alhuneafat, Meghan MannelloLana Al-Rashdan, Morris M. Kim, Jason Dungu, Kevin Alexander & Ahmad Masri. (2021) Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review . Circulation: Genomic and Precision Medicine 14:5.
Crossref
Angelo Giuseppe Caponetti, Claudio Rapezzi, Christian Gagliardi, Agnese Milandri, Angela Dispenzieri, Arnt V. Kristen, Jonas Wixner, Mathew S. Maurer, Pablo Garcia-Pavia, Ivailo Tournev, Violaine Planté-Bordeneuve, Douglass Chapman, Leslie Amass, Johan van Cleemput, Marcia Waddington-Cruz, Hartmut Schmidt, Klaus-Ulrich Dillmann, Henning Mølgaard, Juan Gonzalez Moreno, Jose Gonzalez Costello, Francisco Munoz Beamud, Lucia Galan Davila, David Adams, Jocelyn Inamo, Olivier Lairez, Giuseppe Vita, Giampaolo Merlini, Calogero Lino Cirami, Marco Luigetti, Michele Emdin, Yoshiki Sekijima, Eun-Seok Jeon, Jeeyoung Oh, Maria Alejandra Gonzalez Duarte Briseno, Hans Nienhuis, Teresa Coelho, Isabel Conceicao, Olga Azevedo, Sorina Badelita, Rayomand Press, Yesim Parman, Sanjiv Shah, Dianna Quan, Tessa Marburger, Michael Polydefkis, Ronald Witteles, Stephen Gottlieb, Nitasha Sarswat, Brian Drachman, David Steidley, Scott Hummel, David Slosky, Daniel Jacoby, Jose Nativi-Nicolau, James Tauras, Sasa Zivkovic, Jose Tallaj & Daniel Lenihan. (2021) Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis. JACC: Heart Failure 9:10, pages 736-746.
Crossref
Jose Nativi‐Nicolau, Daniel P. Judge, James E. Hoffman, Balarama Gundapaneni, Denis Keohane, Marla B. Sultan & Martha Grogan. (2021) Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT. ESC Heart Failure 8:5, pages 3875-3884.
Crossref
Matthew Capustin & William H. Frishman. (2021) Transthyretin Cardiac Amyloidosis and Novel Therapies to Treat This Not-so-rare Cause of Cardiomyopathy. Cardiology in Review 29:5, pages 263-273.
Crossref
Yuri Ochi, Toru Kubo, Yuichi Baba, Kenta Sugiura, Motoko Ueda, Kazuya Miyagawa, Tatsuya Noguchi, Takayoshi Hirota, Tomoyuki Hamada, Naohito Yamasaki & Hiroaki Kitaoka. (2021) Wild-Type Transthyretin Amyloidosis in Female Patients ― Consideration of Sex Differences ―. Circulation Reports 3:8, pages 465-471.
Crossref
Solomon S. Beyene, Omar Yacob, Gebremedhin D. Melaku, Alexandre Hideo-Kajita, Kayode O. Kuku, Echo Brathwaite, Vanessa Wilson, Kazuhiro Dan, Ajay Kadakkal, Farooq Sheikh, Selma Mohammed & Hector M. Garcia-Garcia. (2021) Comparison of Patterns of Coronary Artery Disease in Patients With Heart Failure by Cardiac Amyloidosis Status. Cardiovascular Revascularization Medicine 27, pages 31-35.
Crossref
Jaya Batra, Hannah Rosenblum, Ersilia M. Defilippis, Jan M. Griffin, Sunil E. Saith, Danilo Gamino, Sergio Teruya, Jeffeny De Los Santos, Stephen Helmke, Daniel Burkhoff & Mathew S. Maurer. (2021) Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis. Journal of Cardiac Failure 27:1, pages 67-74.
Crossref
Marianna Bruno, Adam Castaño, Arianna Burton & Justin L. Grodin. (2020) Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges. Heart Failure Reviews 26:1, pages 35-45.
Crossref
S. N. Nasonova, I. V. Zhirov, M. M. Magomedov, M. A. Saidova, Yu. F. Osmolovskaya & S. N. Tereschenko. (2020) Experience with tafamidis in a patient with transthyretin amyloidosis. Kardiologiia 60:3, pages 155-160.
Crossref
Deepa M. Gopal, Frederick L. Ruberg & Omar K. Siddiqi. (2019) Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Current Heart Failure Reports 16:5, pages 180-188.
Crossref
Massimiliano Lorenzini & Perry M Elliott. (2019) Tafamidis for the treatment of transthyretin amyloidosis. Future Cardiology 15:2, pages 53-61.
Crossref
Alejandra González-Duarte, Karla Cárdenas-Soto, Carlo Enrico Bañuelos, Omar Fueyo, Carolina Dominguez, Benjamín Torres & Carlos Cantú-Brito. (2018) Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases. Orphanet Journal of Rare Diseases 13:1.
Crossref
Aisha Siraj, Rimsha Hasan & Sabha Bhatti. 2018. Gender Differences in the Pathogenesis and Management of Heart Disease. Gender Differences in the Pathogenesis and Management of Heart Disease 63 77 .
Federico Perfetto, Franco Bergesio, Elisa Grifoni, Alessia Fabbri, Gabriele Ciuti, Sabrina Frusconi, Paola Angelotti, Valentina Spini & Francesco Cappelli. (2016) Different NT-proBNP circulating levels for different types of cardiac amyloidosis. Journal of Cardiovascular Medicine 17:11, pages 810-817.
Crossref
Yesim Parman, David Adams, Laura Obici, Lucía Galán, Velina Guergueltcheva, Ole B. Suhr & Teresa Coelho. (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe. Current Opinion in Neurology 29:Supplement 1, pages S3-S13.
Crossref
Ole B. Suhr, Marie Larsson, Bo-Göran Ericzon & Henryk E. Wilczek. (2016) Survival After Transplantation in Patients With Mutations Other Than Val30Met. Transplantation 100:2, pages 373-381.
Crossref
Sandra Arvidsson, Björn Pilebro, Per Westermark, Per Lindqvist & Ole B. Suhr. (2015) Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition. PLOS ONE 10:11, pages e0143456.
Crossref
Andrew N. Rosenbaum & Brooks S. Edwards. (2015) Current indications, strategies, and outcomes with cardiac transplantation for cardiac amyloidosis and sarcoidosis. Current Opinion in Organ Transplantation 20:5, pages 584-592.
Crossref
Gina Gregorini, Claudia Izzi, Pietro Ravani, Laura Obici, Nadia Dallera, Andrea Del Barba, Alessandro Negrinelli, Regina Tardanico, Matilde Nardi, Luciano Biasi, Tiziano Scalvini, Giampaolo Merlini & Francesco Scolari. (2015) Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney International 87:6, pages 1223-1229.
Crossref
Claudio Rapezzi, Massimiliano Lorenzini, Simone Longhi, Agnese Milandri, Christian Gagliardi, Ilaria Bartolomei, Fabrizio Salvi & Mathew S. Maurer. (2015) Cardiac amyloidosis: the great pretender. Heart Failure Reviews 20:2, pages 117-124.
Crossref
Adam Castaño, Brian M. Drachman, Daniel Judge & Mathew S. Maurer. (2014) Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Failure Reviews 20:2, pages 163-178.
Crossref
Morie A. Gertz, Angela Dispenzieri & Taimur Sher. (2014) Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology 12:2, pages 91-102.
Crossref
Violaine Plante-Bordeneuve. (2014) Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy. Journal of Neurology 261:6, pages 1227-1233.
Crossref
Sven Meyer, Peter van der Meer, J. Peter van Tintelen & Maarten P. van den Berg. (2014) Sex differences in cardiomyopathies. European Journal of Heart Failure 16:3, pages 238-247.
Crossref
Honey V. Reddi, Sarah Jenkins, Jason Theis, Brittany C. Thomas, Lawreen H. Connors, Frits Van Rhee & W. Edward HighsmithJr.Jr.. (2014) Homozygosity for the V122I Mutation in Transthyretin Is Associated with Earlier Onset of Cardiac Amyloidosis in the African American Population in the Seventh Decade of Life. The Journal of Molecular Diagnostics 16:1, pages 68-74.
Crossref
Shuk Wai Ho, Yuk Tung Chanel Tsui, Ting Ting Wong, Stanley Kwok-Kuen Cheung, William B Goggins, Lau Ming Yi, Kwok Kin Cheng & Larry Baum. (2013) Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease. Translational Neurodegeneration 2:1.
Crossref
Masayoshi Tasaki,Mitsuharu Ueda, Konen Obayashi, Haruki Koike, Keisuke Kitagawa, Yasuhiro Ogi, Hirofumi Jono, Yu Su, Genki Suenaga, Toshinori Oshima, Yohei Misumi, Mari Yoshida, Taro Yamashita, Gen Sobue & Yukio Ando. (2013) Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach. International Journal of Cardiology 170:1, pages 69-74.
Crossref
Michele Boldrini, Francesco Salinaro, Roberta Mussinelli, Ambra Raimondi, Alessio Alogna, Francesco Musca, Giovanni Palladini, Giampaolo Merlini & Stefano Perlini. (2013) Prevalence and Prognostic Value of Conduction Disturbances at the Time of Diagnosis of Cardiac AL Amyloidosis. Annals of Noninvasive Electrocardiology 18:4, pages 327-335.
Crossref
Arnt V. Kristen, Sabine Haufe, Stefan O. Schonland, Ute Hegenbart, Philipp A. Schnabel, Christoph Röcken, Stefan Hardt, Peter Lohse, Anthony D. Ho, Uwe Haberkorn, Thomas J. Dengler, Klaus Altland & Hugo A. Katus. (2013) Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. International Journal of Cardiology 164:2, pages 179-184.
Crossref
C. Rapezzi, C. C. Quarta, L. Obici, F. Perfetto, S. Longhi, F. Salvi, E. Biagini, M. Lorenzini, F. Grigioni, O. Leone, F. Cappelli, G. Palladini, P. Rimessi, A. Ferlini, G. Arpesella, A. D. Pinna, G. Merlini & S. Perlini. (2012) Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. European Heart Journal 34:7, pages 520-528.
Crossref
Brandt L. Esplin & Morie A. Gertz. (2013) Current Trends in Diagnosis and Management of Cardiac Amyloidosis. Current Problems in Cardiology 38:2, pages 53-96.
Crossref
V. Planté-Bordeneuve & P. Kerschen. 2013. Peripheral Nerve Disorders. Peripheral Nerve Disorders 643 658 .
P. Kerschen & V. Planté-Bordeneuve. (2012) Neuropatie amiloidi familiari. EMC - Neurologia 12:1, pages 1-12.
Crossref
Violaine Planté-Bordeneuve & Gerard Said. (2011) Familial amyloid polyneuropathy. The Lancet Neurology 10:12, pages 1086-1097.
Crossref
Pablo García-Pavía, María Teresa Tomé-Esteban & Claudio Rapezzi. (2011) Amiloidosis. También una enfermedad del corazón. Revista Española de Cardiología 64:9, pages 797-808.
Crossref
Pablo García-Pavía, María Teresa Tomé-Esteban & Claudio Rapezzi. (2011) Amyloidosis. Also a Heart Disease. Revista Española de Cardiología (English Edition) 64:9, pages 797-808.
Crossref
. (2011) Abstracts. Amyloid 18:Suppl. 1, pages 6-238.
Crossref
Federico Perfetto, Francesco Cappelli & Franco Bergesio. (2011) Asymptomatic homozygous gene carrier in a family with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany?. Journal of Cardiovascular Medicine 12:6, pages 450-451.
Crossref
Sadahisa Okamoto, Rolf Hörnsten, Konen Obayashi, Priyantha Wijayatunga & Ole B. Suhr. (2011) Continuous development of arrhythmia is observed in swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). Liver Transplantation 17:2, pages 122-128.
Crossref
P. Kerschen & V. Planté-Bordeneuve. (2011) Neuropathies amyloïdes familiales. EMC - Neurologie 8:4, pages 1-12.
Crossref
Claudio Rapezzi, Candida Cristina Quarta, Letizia Riva, Simone Longhi, Ilaria Gallelli, Massimiliano Lorenzini, Paolo Ciliberti, Elena Biagini, Fabrizio Salvi & Angelo Branzi. (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nature Reviews Cardiology 7:7, pages 398-408.
Crossref
Barbara Kieninger, Magdalena Eriksson, Reinhard Kandolf, Philipp A. Schnabel, Stefan Schönland, Arnt V. Kristen, Ute Hegenbart, Peter Lohse & Christoph Röcken. (2010) Amyloid in endomyocardial biopsies. Virchows Archiv 456:5, pages 523-532.
Crossref
Ingrid I. van Gameren, Bouke P. C. Hazenberg, Johan Bijzet, Elizabeth B. Haagsma, Edo Vellenga, Marcel D. Posthumus, Pieter L. Jager & Martin H. van Rijswijk. (2010) Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis. Arthritis Care & Research 62:3, pages 296-301.
Crossref
James Kenn CHAMBERS, Takuya KANDA, Atsushi SHIRAI, Keiichi HIGUCHI, Shu-ichi IKEDA & Yumi UNE. (2010) Senile Systemic Amyloidosis in an Aged Savannah Monkey (Cercopithecus aethiops) with Tenosynovial Degeneration. Journal of Veterinary Medical Science 72:5, pages 657-659.
Crossref
Sadahisa Okamoto, Jonas Wixner, Konen Obayashi, Yukio Ando, Bo-Göran Ericzon, Styrbjörn Friman, Makoto Uchino & Ole B. Suhr. (2009) Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transplantation 15:10, pages 1229-1235.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.